KRAS and non-small cell lung carcinoma: Previous studies by our group and others have presented the landscape and the therapeutic relevance of allele-specific KRAS and EGFR alterations in non-sq NSCLC; yet, these studies have lacked or had limited information on ancestry-specific patterns26,34,35.